Biocon Ltd. — Interim / Quarterly Report 2020

Oct 25, 2019

Biocon Limited

20th KM Hosur Road Electronics City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA 1978PLC003417

October 25, 2019

	www.biocon.com
To	To
The Secretary	The Secretary
BSE Limited	National Stock Exchange of India Limited
Department of Corporate Services	Corporate Communication Department
Phiroze Jeejeebhoy Towers,	Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai-400 001	Mumbai-400 050
Scrip Code - 532523	Scrip Symbol- Biocon

Dear Sir/Madam,

Subject:- Newspaper Advertisement- Financial Results Q2 FY20

In continuation to our letter dated October 23, 2019 with regard to Financial Results for the quarter and half year ended September 30,2019, please find enclosed the copies of newspaper advertisement published in Financial Express (English Language - All India Edition) and Vijayavani (Kannada - Bengaluru Edition) on October 25, 2019.

The above information is also made available on the website of the Company at https://www.biocon.com/biocon invrelation disclosure SE.asp.

Request you to kindly take the same on record.

Thanking you, For Biocon Limited

Enclosed: Copies of Newspaper advertisements

	Particulars	3 months ended30 09 2019	6 months ended30.09.2019	3 monthsended 30.09.2018
		(Unaudited)	(Unaudited)	(Unaudited)
	Total income from operations	15,722	30.381	13.210
Ñ	Net profit before share of profit of joint venture and associates,tax, exceptional items and non-controlling interest	2,958	6,166	2.630
	Net profit before tax and non-controlling interest	3.539	6,668	4.509
IV.	Net profit after tax and non-controlling interest	2.157	4.220	3.547
v	Total comprehensive income for the period attributable toshareholders [comprising profit for the period (after tax) andother comprehensive income (after tax)]	1,799	3.309	3.321
VI.	Paid-up equity share capital [Face value of Rs. 5 each]	6,000	6.000	3,000
VII	Earnings per share [of Rs. 5 each](a) Basic(b) Diluted	(not annualised)1.821.82	(not annualised)3.573.56	(not annualised)3.002.98
1.	Key standalone financial information(Rs. in Million)
	Particulars	3 months ended30.09.2019	6 months ended30.09.2019	3 months ended30.09.2018
		(Unaudited)	(Unaudited)	(Unaudited)
	Continuing operations
	Total income from operations	5,239	10.047	4.567
	Profit before tax	1,257	2.819	1.175
п	Profit after tax	1,000	2.220	1,000
ш
	Discontinuing/discontinued operations
	Profit before tax	169	117	234

Vijayavani dated October 25, 2019

	Resources for CAPPersonBisson Limited20th KM Hissur Road,Emeteriale fliry MO.Bangalore 550 100.Peak, hipcocia SoinCIN LAGUAKA1928PCC003412	$\mathcal{\mathcal{S}}$ Biocon
EXTRACT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED SEPTEMBER 30, 2019(Rs. in Million, except per equity share data)
	Particulars	3 months ended30.09.2019	6 months ended30.09.2019	3 monthsended 30.09.2018
		(Unaudited)	(Unaudited)	(Unaudited)
	Total income from operations	15,722	30,381	13,210
	Net profit before share of profit of joint venture and associates,tax, exceptional items and non-controlling interest	2,958	6,166	2,630
Ш	Net profit before tax and non-controlling interest	3,539	6,668	4,509
IV	Net profit after tax and non-controlling interest	2,157	4,220	3,547
V	Total comprehensive income for the period attributable toshareholders [comprising profit for the period (after tax) andother comprehensive income (after tax)]	1,799	3,309	3,321
٧I	Paid-up equity share capital [Face value of Rs. 5 each]	6,000	6,000	3,000
VII	Earnings per share [of Rs. 5 each](a) Basic(b) Diluted	(not annualised)1.821.82	(not annualised)3.573.56	(not annualised)3.002.98
	1. Key standalone financial information(Rs. in Million)
	Particulars	3 months ended30.09.2019	6 months ended30.09.2019	3 months ended30.09.2018
		(Unaudited)	(Unaudited)	(Unaudited)
	Continuing operations
L	Total income from operations	5,239	10,047	4,567
H	Profit before tax	1,257	2,819	1,175
Ш	Profit after tax	1,000	2,220	1,000
	Discontinuing/discontinued operations
	Profit before tax	169	117	234
Ш.	Profit after tax	61	(40)	198
	2. The unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2019 in respect ofBiocon Limited ('the Company') have been reviewed by the Audit Committee and approved by the Board of Directors of theCompany at their respective meetings held on October 23, 2019. The above results have been subjected to limited review by thestatutory auditors of the Company. The reports of the statutory auditors are unqualified.			3. These financial results have been prepared in accordance with Indian Accounting Standards ('Ind AS') prescribed under Section 133